Knightsbridge Asset Management’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Knightsbridge Asset Management’s Portfolio IBBQ Stock Details IBBQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$957K	Hold	29,300	–	–	0.13%	88
2026 Q1	$849K	Hold	29,300	–	–	0.11%	93
2025 Q4	$832K	Hold	29,300	–	–	0.13%	78
2025 Q3	$712K	Hold	29,300	–	–	0.12%	82
2025 Q2	$619K	Hold	29,300	–	–	0.14%	80
2025 Q1	$621K	Hold	29,300	–	–	0.16%	74
2024 Q4	$631K	Hold	29,300	–	–	0.15%	81
2024 Q3	$697K	Hold	29,300	–	–	0.16%	71
2024 Q2	$667K	Hold	29,300	–	–	0.17%	66
2024 Q1	$641K	Hold	29,300	–	–	0.18%	68
2023 Q4	$641K	Buy	+29,300	New	+$577K	0.18%	68

Other funds holding IBBQ

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

WMS Group Folsom, Louisiana $77.5M AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

IAA

Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

CFA

Churchill Financial Advisors Louisville, Kentucky $519M AUM

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Knightsbridge Asset Management's IBBQ Position: Q2 2026 in Review

Knightsbridge Asset Management held its Invesco NASDAQ Biotechnology ETF (IBBQ) position steady in Q2 2026 at 29,300 shares worth $957K. The position accounts for 0.13% of the portfolio, ranked #88.

Knightsbridge Asset Management first reported a position in IBBQ in Q4 2023 and has held it in 11 quarters since. 35 funds tracked by Wall St. Rank hold IBBQ as of Q2 2026.

Knightsbridge Asset Management held 29,300 shares of Invesco NASDAQ Biotechnology ETF worth $957K as of Q2 2026.
Knightsbridge Asset Management left its Invesco NASDAQ Biotechnology ETF share count unchanged in Q2 2026.
Invesco NASDAQ Biotechnology ETF made up 0.13% of Knightsbridge Asset Management's portfolio in Q2 2026, its #88 holding.
Knightsbridge Asset Management first reported a position in Invesco NASDAQ Biotechnology ETF in Q4 2023 and has held it in 11 quarters since.
35 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q2 2026.

Based on Knightsbridge Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.